” While the Ricaurte story was unfolding, MAPS ultimately gained FDA sign-off over a protocol for human trials of MDMA to be a therapy for PTSD, but only soon after it bought a $1 million coverage plan to indemnify the review board.MK-Ultra, a CIA project begun during the nineteen fifties, worked on the applying of psychedelics for thoughts contr